Era of direct acting anti-viral agents for the treatment of hepatitis C. [PDF]
Hepatitis C infection is universal and the most common indication of liver transplantation in the United States. The period of less effective interferon therapy with intolerable side effects has gone.
Ahmed, Monjur
core +1 more source
Seroprevalence of viral transfusion transmissible infections (HBsAg, anti-HCV, anti-HIV, Syphilis) and coinfection among healthy volunteer blood donors during 5-years in Luanda, Angola. [PDF]
Quintas AE +4 more
europepmc +1 more source
Approximately 4.1 million Americans have been infected with HCV and 45-85% of chronically infected persons are unaware of their status. Rapid anti-HCV assays can assist and expedite the identification of those unaware of their infection.
core
HBV/HCV co-infection in Iran: A seroepidemiological based study
The aim of this study was to determine the seroprevalence of HCV in HBsAg positive subjects. In a population based single stage cluster sampling in Golestan province of Iran, 139 HBsAg positive subjects were detected and enrolled in the study.
Abdolahi, N. +12 more
core +1 more source
The Relationship Between Anti-HCV Screening and Clinical Features of Inpatients in Addiction Center. [PDF]
Karabulut S.
europepmc +1 more source
Objectives: Regular blood transfusions are essential for patients with thalassaemia major. However, infections with hepatotropic viruses remain a major concern. The objective of this study was to evaluate the prevalence and characteristics of hepatitis C
Khalid Al-Naamani +4 more
doaj +2 more sources
PERSPECTIVES OF TREATMENT OF TERMINAL LIVER DISEASE IN CHRONIC HCV-INFECTION
Aim. Assessment of role of HBV viral proteins in liver disease progression in chronic HCV-infected patients.Methods. 2934 patients were included into the study, in whom serological markers of HBV- and HCV-infection were evaluated.
E. N. German +4 more
doaj
Hepatitis C Virus Genotyping from anti-HCV Negative Sera in Blood Donors
Supiana Dian Nurtjahyani +1 more
openalex +2 more sources
Uji Saring Antigen dan Antibodi Hepatitis C Virus pada Darah Donor [PDF]
According to the data from Central Blood Transfusion Unit, the prevalence of hepatitis C virus (HCV) in blood donors in Indonesia and especially Jakarta in 2012 were 0.39% and 0.36% respectively.
Ibrahim, F. (Fera) +3 more
core
Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis. [PDF]
Türkoğlu E, Parlak Z, Barut HŞ.
europepmc +1 more source

